Corrigendum to “Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity” (Eur. J. Med. Chem. (2012) 55 (220–227)(S0223523412004497)(10.1016/j.ejmech.2012.07.023))

Kuen Feng Chen, Wei Tien Tai, Cheng Yi Hsu, Jui Wen Huang, Chun Yu Liu, Pei Jer Chen, In Ki Kim, Chung Wai Shiau*

*Corresponding author for this work

Research output: Contribution to journalComment/debate

1 Scopus citations

Abstract

The authors regret for the mistake occurred in Figure 6B. The corrected figure is shown below. The result and conclusions in the article remain unchanged. The authors would like to apologise for any inconvenience caused.

Original languageEnglish
Pages (from-to)2015
Number of pages1
JournalEuropean Journal of Medicinal Chemistry
Volume143
DOIs
StatePublished - 1 Jan 2018

Fingerprint

Dive into the research topics of 'Corrigendum to “Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity” (Eur. J. Med. Chem. (2012) 55 (220–227)(S0223523412004497)(10.1016/j.ejmech.2012.07.023))'. Together they form a unique fingerprint.

Cite this